HIF1A and familial pancreatic carcinoma: In addition, we present distinctive molecular profiles and critical oncogenic pathways for tumors with low/medium HIF-1 scores and high HIF-1 scores, which provide distinctive strategies for treating these pancreatic cancers individually.